This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Sanofi breast cancer drug amcenestrant has failed in a Phase 3 clinical trial, leading the pharmaceutical giant to discontinue all clinical development of the small molecule. The move means Sanofi is out of the competitive chase to develop a so-called “oral SERD” therapy for patients with a certain type of breast cancer.
A new report, ‘ Enhancing the role of UK medicine regulation ’ by the Association of the British Pharmaceutical Industry (ABPI) explores the key role that regulatory excellence has in driving innovation and early treatment access for patients, as well bringing investment into the UK.
And, it can increase patient volume and revenue. And when woven into your content marketing strategy, a strong value proposition becomes essential for increasing patient volume and revenue in the healthcare industry. That’s why your value proposition is crucial for attracting new patients and ensuring long-term loyalty.
What’s more, your highest revenue service lines are likely already facing stiff competition from all angles. . For these reasons and more, it’s imperative to identify your unique selling propositions, review them, and revise them regularly to remain competitive. . So, how can your brand stay competitive? The answer is twofold.
Forward by Stewart Gandolf, Chief Executive Officer At Healthcare Success, we understand that a patients journey often beings with a search query. Symptom search optimization is crucial for: Guiding patient journeys. These symptom-based searches represent the initial touchpoint in the modern patient acquisition funnel.
Deeply Understand Your Market and Audience To create a leading product, you need to understand the therapeutic area thoroughly. Equally important is understanding your target audience—patients, healthcare professionals, regulators, and payers. Invest in strategies that allow you to engage healthcare professionals and patients directly.
Imagine a time when pharmaceutical ads simply told patients what to ask their doctor. Today, patient marketing is no longer a one-way street. For pharma marketing executives and brand teams, understanding this evolution is essential to remaining competitive and compliant in a rapidly shifting healthcare environment.
Unlock the secrets of simplifying complex medical procedures and fast-track your career in the competitive medical sales industry. Learn how a serendipitous summer with a host family in Colorado pivoted his career aspirations towards medical sales, leading to impactful roles with industry giants like Smith & Nephew.
It’s often stated – mostly without reference to data – that the environment for innovative launches is more competitive now than it ever has been. Continued competitive intensity. The first in class launches barely have time to establish before they face competition, and then the competition keeps on coming.
to address the potential competitive harm Amgen’s $27.8 Consolidation in the pharmaceutical industry has given companies the power and incentive to engage in exclusionary rebating practices, which can lead to sky-rocketing prices on essential medications,” stated Henry Liu, Director of the FTC’s Bureau of Competition.
DTC ads do NOT lead to unnecessary Rxs. Here are some myths around DTC marketing: 1ne: DTC ads result in patients asking for prescriptions they don’t need. Drug pricing is done by internal teams who look at what the market will bear and the competitive landscape. DTC ads raise awareness around health conditions.
In an increasingly digital healthcare landscape, keeping patients engaged has become a top priority for providers. By integrating game-like elements into patient care, healthcare providers can drive better health outcomes, enhance patient loyalty, and improve overall satisfaction. billion dollars.
Discover how she leveraged her clinical background to drive innovation and improve patient outcomes, particularly in preventing amputations for those with peripheral arterial disease. Despite having no formal sales training, her deep clinical expertise and firsthand understanding of patient care have propelled her to excel in the field.
Among the best ways to serve patients and help healthcare providers communicate about a condition or product is with empathetic approaches that mirror where patients are in their lives, and consider their frustrations and discontents as well as what makes them satisfied and in control.
Nuvera is a leading consulting firm dedicated to designing, building, and measuring patient and HCP treatment experiences for rare diseases, specialty medicines, and cell and gene therapeutics. For 15 years, Nuvera has helped clients enhance specialty product engagement by delivering data-driven patient experience solutions.
Artificial intelligence (AI) is rapidly revolutionizing the healthcare industry, reshaping the patient experience in the process. By leveraging AI in patient care, healthcare providers can improve patient outcomes, enhance efficiency, and reduce costs all while providing a more personalized and seamless patient experience.
The pharmaceutical industry is facing a number of challenges, including increasing competition, rising costs, and changing regulations. In order to succeed in this challenging environment, pharmaceutical companies need to adopt a patient-centric approach to marketing. One way is to use patient-generated content (PGC).
Now is the right time to appoint my successor given our competitive growth outlook, new product launches expected from the second half of 2026 onwards” Julie is an outstanding leader who has made significant contributions to the company, notably in leading the US business and the Plasma-Derived Therapies Business Unit previously.
With the rapid expansion of digital platforms, evolving patient expectations, and the increasing role of AI-driven marketing, pharmaceutical companies and healthcare brands are allocating more resources to advertising in 2025. Patients and healthcare providers are more reliant on online information than ever before.
Since that time, Biogen’s MS drugs have faced intense competition as MS patients continue to vent on social media that the Biogen drug has nasty side effects. Biogen concluded the key to effectiveness was giving patients a high-enough dose, but critics howled, with one calling the analysis “a post hoc dumpster dive operation.”
These changes include modernizing business processes and focusing on improvements that positively impact patient wait times and appointment times. . It is well-established that longer patient wait times negatively impact patient satisfaction , specifically regarding patient confidence (in the provider) and perceived quality of care.
But in an industry with strict regulations, high competition, and complex audience needs , landing page optimization for pharmaceutical brands requires a strategic and compliant approach. It must convert visitors into leads , provide clear and accurate medical information , and ensure compliance with FDA, HIPAA, and ad platform policies.
New book sets the pharmaceutical industry on a course for bridging the patient centricity optimism gap. Bridging the gulf between patient centricity ambition and reality has never been more important for pharma – luckily, this seemingly insurmountable goal isn’t as far out of reach as many envision. And that is driving change.”.
However, patient uptake hasn’t matched rising market competition. And among patients who have tried preventive medications for migraine, 39% said they no longer took them. Only about half of those living with migraine (52%) have tried acute therapy, and just 37% have investigated preventive therapy, the survey found.
Purplemoon and Takeda Oncology Dont Compromise Alunbrig needed a bold and differentiating new campaign to stand out in an increasingly competitive market.
With strict regulations, increasing competition, and evolving ad platform policies, running a successful PPC campaign in pharma isnt as straightforward as in other industries. This guide breaks down best practices for PPC campaign optimization , helping pharma marketers reach HCPs and patients without wasting ad spend.
The Power of Visibility: How Leading Healthcare Brands Stay Top-of-Mind in Tough Times Learning from History Healthcare organizations that maintained their marketing and advertising investments during past recessions saw faster post-recession growth and increased market share. Healthcare advertising is critical, even in a downturn.
However, in the meantime patients will be deprived access to the most innovative products and R&D will migrate out of Europe. The absence of adequate infrastructure mirrors the issues encountered by MDR and IVDR, leading to delays because notified bodies were not adequately prepared and did not have adequate capacity.
For pharma marketing executives and their teams, staying current helps maintain competitive advantage, ensures compliance, and unlocks opportunities for smarter, faster campaign decisions. Moreover, understanding the latest developments in AI, digital health, and patient engagement can position your team to adapt early.
Yet in healthcare, one of the most critical services, patients often face barriers to access and information. Fortunately, technology is bridging this gap, empowering patients to take a more active role in healthcare. Photo by stevepb on Pixabay Top Benefits of Improving Patient Access 1.
With increasing competition, strict regulations, and changing consumer behavior, pharmaceutical brands must embrace digital transformation to stay relevant. Think of digital marketing as the GPS guiding your brand through a crowded, competitive landscape. Improve patient engagement with valuable content and resources.
The digital landscape has transformed how pharmaceutical brands reach healthcare professionals (HCPs) and patients. But how do you make your campaigns stand out in such a highly regulated and competitive industry? Use these channels to run awareness campaigns, engage with patient communities, or even share educational content.
A new industry survey from the Biotechnology Innovation Organization (BIO) highlights the vulnerability of supply that proposed tariffs would put on medicines, and its impact on patient access. As such, IGBA is pushing for trade policies that promote economic growth while safeguarding medicines access.
In pharma, this includes gathering information from a variety of sourcesclinical, behavioral, demographic, and digitalto improve how brands connect with healthcare professionals (HCPs) and patients. It’s your competitive edge. Traditionally, pharmaceutical marketing relied on broad segmentation and static content.
It’s about knowing what the market wants, understanding your competition, and predicting the next trend before it happens. In this article, we’ll break it down, explaining how you can leverage market research to not just survive but thrive in the ever-competitive pharma world. That’s where competitive analysis comes in.
Table of Contents The New Rules of Pharma SEO Building Authority with Content That Ranks Optimizing for HCPs and Patients Differently Future-Proofing with AI and Data Insights Final Thoughts FAQs The New Rules of Pharma SEO The pharmaceutical space comes with unique SEO challenges. Another major change? Search is now more conversational.
With competition intensifying and regulations becoming stricter, crafting impactful campaigns requires both creativity and precision. For instance, while patients prioritize benefits and side effects, healthcare providers look for clinical evidence and efficacy. Missteps can lead to hefty fines and reputational damage.
Which platforms provide valuable insights for reaching healthcare professionals (HCPs) and patients? Digital platforms provide a way to streamline outreach efforts, measure campaign performance, and engage with both healthcare professionals and patients.
4DMT had paused enrollment of patients to two of its trials for 4D-310 last month following a significant adverse event where three patients experienced kidney issues; however, these were treated and resolved in a four-week period.
While it offers precise targeting, competition for high-intent HCP audiences can drive up costs. Direct Access to High-Intent Audiences Pharma brands need to reach HCPs actively seeking information on new treatments, clinical research, or patient management tools. Brand-related keywords to ensure visibility in competitive markets.
Struggling with burnout while maintaining high-quality healthcare services that patients love? Tune in to our latest podcast as Lee Aase, founder of HELPCare, LLC, shares how he transitioned from his pioneering social media work at Mayo Clinic to lead an innovative membership-based direct-to-patient healthcare business.
The pharmaceutical industry is competitive, fast-paced, and highly regulated, making it essential for marketers to stay ahead of trends, build strong industry relationships, and continuously improve their strategic thinking. Using data visualization, storytelling, and patient case studies can make scientific content more compelling.
While the goal is ultimately to improve patient outcomes, the competitive nature of the industry can sometimes lead to ethical dilemmas. Ethical considerations in medical sales require constant vigilance and a commitment to putting patient well-being at the forefront of every interaction. Rep-Lite can help!
Whether you’re exploring digital ad retargeting, AI compliance, or the latest branded drug campaigns, this resource hub helps pharma marketers stay competitive. You might also discover new content automation platforms or patient engagement models that you can present during your next team sync. Absolutely.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content